Drugs

Order of the Supreme Court regarding ART drugs for people living with HIV/AIDS, 24/02/2025

Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …

Pilot project in Mumbai for TB treatment in urban areas

The public health scare over totally drug resistant TB ended on a fruitful note for the city-Mumbai will be the site of an ambitious pilot project to combat tuberculosis in an urban setting. It spells more attention, more hospital beds and money for TB control. Each of the city's 24 …

Pharmaceutical industry: Investors unfazed by drug-patent expiry

Your data on changing stock prices for five pharmaceutical companies from 1997 to 2010 (Nature 480, 16–17; 2011) erroneously indicate a 39% drop in aggregated share value, when in fact it would have risen by 82% (see Correction, Nature 480, 425; 2011). The error was due mainly to the selection …

Hospital creating unnecessary alarm: Health ministry

Refuting the claims of Hinduja Hospital that claimed to have detected 12 cases of “total drug resistant” tuberculosis, the Union health ministry on Tuesday said that the isolates collected from Maharashtra have infact shown that there was not yet any case of extensive drug resistant (XDR) tuberculosis. “Preliminary results of …

Central team in Mumbai to take stock of drug-resistant TB cases

A Central team deputed by the Union Health and Family Welfare arrived here to ascertain the “facts” about the reports suggesting that 12 patients were “diagnosed” with Totally Drug Resistant Tuberculosis (TDR-TB) in Hinduja hospital. A day after it arrived in the city from the capital on Monday, the Central …

New strategy to deal with drug-resistant TB

The civic administration on Monday decided upon a three-pronged strategy to deal with Total Drug Resistant Tuberculosis (TDR-TB) reported by a city hospital, Manisha Mhaiskar, Additional Municipal Commissioner of the Municipal Corporation of Greater Mumbai, told reporters here. Private practitioners will now have to refer all TB cases or those …

Rules tighten on use of antibiotics on farms

Alarmed at signs that the overuse of antibiotics in farm animals is blunting these key weapons against human disease, governments are taking action.

Drug-resistant TB cases in Mumbai rattle experts

The emergence of drug-resistant tuberculosis in the country has sparked off a major health alert with researchers in Mumbai warning that lack of cure could result in heavy casualties. Doctors at the Hinduja Hospital here have recorded 12 cases of Total Drug Resistant TB over the past three months. Ten …

First cases of totally drug resistant TB in India, one dead

This is as scary as it can get. The PD Hinduja hospital detected four people with total drug resistant (TDR) tuberculosis (TB), the first such cases in the country till November last year. In the last two months, eight others have been detected with TDR-TB. Of the 12 patients, a …

Mumbai hospital reports first set of ‘total’ drug-resistant TB cases

Almost three years after the first set of patients were diagnosed with Totally Drug-Resistant Tuberculosis (TDR-TB) in Iran, researchers at the P D Hinduja National Hospital and Medical Research Centre here said today they have detected India’s first set of TDR-TB patients — 12 over the past two months. In …

UP wakes to drug-resistant TB challenge

LUCKNOW: Every second Indian undergoing treatment for tuberculosis comes from Uttar Pradesh. Considering that 17% of tuberculosis (TB) patients eventually become resistant to basic anti-TB treatment, the risk of multi drug resistant TB (MDR TB) looms large over the state. However, this was probably not enough to put health authorities …

Vetting pharma M&As out of ambit, says CCI

New Delhi: The government’s move to get all acquisition of local pharmaceutical companies by overseas players vetted by the Competition Commission of the India (CCI) has run into trouble. CCI, the anti-monopoly watchdog, has told the government that the law does not empower it to monitor and restrict merger or …

Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: A database analysis

Reed Beall and Randall Kuhn describe their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995. Original Source

Government plans for new rule for clinical trials

The central government’s plans to introduce a new rule under the existing Drugs and Cosmetics Act to compensate clinical trial victims has been challenged before the Lucknow bench of the Allahabad High Court. In a public interest petition (PIL), Lucknow based health activist Raahul Dutta has questioned several provisions in …

Free medicare for 50 lakh poor families in Maharashtra

Maharashtra government will spend Rs. 800 crore on the first phase of a health scheme for the poor, which is slated to benefit nearly 50 lakh families from eight districts, Maharashtra Deputy Chief Minister Ajit Pawar said at a function here on Wednesday. Under the ‘Rajiv Gandhi Jeevandayee Arogya Yojana,' …

Vaccinomics and personalized vaccinology: Is science leading us toward a new path of directed vaccine development and discovery?

As is apparent in many fields of science and medicine, the new biology, and particularly new high-throughput genetic sequencing and transcriptomic and epigenetic technologies, are radically altering our understanding and views of science. In this article, we make the case that while mostly ignored thus far in the vaccine field, …

Drug Cos told to pay 4,000cr Penalty

Bombay HC refuses to stay 1996 notice to 500 companies on overcharging for bulk drugs More than 500 Indian drug companies will have to collectively pay over . 4,000 crore in dues after a high court shot down their petition challenging penalty notices sent by drug authorities for overcharging. Special …

Ranbaxy to pay US FDA $500m

Mumbai: Japanese drug major Daiichi has lowered its profit forecast for the year ending March 2012, and slashed senior executive pay, to offset the impending loss arising out of its Indian subsidiary, Ranbaxy’s $500-million legal settlement in the US. After months of sticky negotiations, Ranbaxy finally announced on Wednesday that …

One step at a time

The repertoire of traditional Chinese medicine could offer rich pickings for modern drug developers, but researchers must first define and test herbal concoctions.

Drugmakers Look to Break Rural Deadlock: Novartis, GlaxoSmithKline, Pfizer & Ranbaxy focus on hinterland

Sample this: India’s rural market accounts for half of two-wheeler sales, a third each of fast-moving consumer goods sales and telephone subscriptions and 60% of gold consumption. In contrast, the drug industry in spite of the importance of medicine still sees the rural market accounting for just 20% of its …

WHO caution ignored, 1.75m wrongly diagnosed with TB

NEW DELHI, 20 DEC: A World Health Organisation (WHO) recommendation to ban use of rapid test kits used to detect tuberculosis in developing countries notwithstanding, there is rampant use of this kit in India that gives “unacceptable levels of wrong results”. A recent study conducted by Indian Council of Medical …

  1. 1
  2. ...
  3. 58
  4. 59
  5. 60
  6. 61
  7. 62
  8. ...
  9. 151

IEP content by date loading...
IEP child categories loading...